NEWS

March 30, 2012

EDMONTON, Alberta – March 30, 2012 – Fedora Pharmaceuticals, Inc. today announced the Company’s incorporation and in-license of exclusive worldwide rights to a family of beta-lactamase inhibitors (BLIs) discovered by scientists at NAEJA Pharmaceutica...

Please reload

Featured Posts

Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle Antimicrobial Resistance with Novel Pipeline of Antibiotic Candidates

January 16, 2017

1/3
Please reload

Recent Posts
Please reload

Archive
Please reload

Follow Us
  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

11629 – 105 Avenue, Edmonton, AB T5H 0L9

      info@fedorapharma.com  |   780-757-5401

© 2017 Fedora Pharmaceuticals Inc. 

  • Facebook - Black Circle
  • LinkedIn - Black Circle